BACK
TO MAIN
PAGE

Gonorrhoea

General Information

Preventable and curable infection caused by the bacterium Neisseria gonorrhoeae.

Increasing antimicrobial resistance to antibiotics have been observed in N. gonorrhoeae.

Currently, no vaccine is licensed for the prevention of gonorrhoea.

Transmission

Sexually-transmitted infection.

Symptoms

Gonorrhoea causes different symptoms in women and men.

Most women with gonorrhea do not have symptoms or do not notice them. If left untreated, gonorrhoea can lead to infertility in both men and women and other sexual and reproductive health complications.

It also increases the risk of HIV infection.

Show More

Epidemiology

2021

In the EU/EEA region in 2021 there were over 46.500 confirmed cases of gonorrhoea.

2020

In 2020 there were an estimated 82.4 million new infections among adults globally.

Vaccines
Pipeline

1
Vaccines in
the pipeline

Technology Platforms

    Generalised Modules for Membrane Antigens (1)

DEVELOPMENT PHASES

  • Phase II (1)

TRIAL POPULATION

    Paediatric + Adults (1)

Source:
WHO. Gonorrhoea (Neisseria gonorrhoeae infection). [Online].; 2023 [cited 2023 August. Available from: https://www.who.int/news-room/fact-sheets/detail/gonorrhoea-(neisseria-gonorrhoeae-infection).
ECDC. Gonorrhoea - Annual Epidemiological Report for 2021; 2023 –cited 2024 January. Available from: https://www.ecdc.europa.eu/en/publications-data/gonorrhoea-annual-epidemiological-report-2021

Vaccines Europe Pipeline Review

Download our pipeline review